Byotrol Share Discussion Threads

[kumbuka] 09/4/2024 10:43

You have been ramping this from 9p all the way down to where it is now and still you are trying to lure mugs into this FAILED company.

[kumbuka] 09/4/2024 10:41

I’m still waiting for an answer stupid mudbath are you paid by BYOT to promote it ?

[mudbath] 09/4/2024 10:18

It looks as though a revised quote of 0.15/0.25p is on its way.
But will this be sufficient to stimulate any selling ?
The result will quite possibly be the exact reverse; leading to further upward movements.

[mudbath] 09/4/2024 10:07

Nice 6,600,000 buy there at 0.169p .
(Equating to another 1%+ of the Byotrol equity)

[loafofbread] 09/4/2024 08:03

I do think 1gw should join the company in some capacity to protect the small PI going forward.

Pretty sure we have over 10% if he needed a mandate from us.

[loafofbread] 09/4/2024 07:55

We have always known that DT and his pals run this as their own private fiefdom.

The £2M wage bill shows how out of control he is.

The whole point of a BOD is that they work in the interests of shareholders.

DT should have negotiated from a position of relative strength and taken offers towards the end of last year. Delisting should have been plan B/C.

The Newlands exit shows what his supporters think of Dt's abilities.

That said the share price has zero reflection on the real value of the business going forward.

[cliffpeat] 09/4/2024 07:36

@loafofbread - thanks for your post 12782 about Animalcare

I was struck by the purposeful, strategic paragraph:

"In 2022 we took a significant step to strengthen our novel pipeline in a pre-clinical collaboration and licensing deal with Orthros Medical, a Netherlands-based research company specialising in VHH antibody technology. Initially focused on treatment of osteoarthritic pain in dogs, we are now extending the investigative programme to horses. Overall, the project is progressing well and we are excited about the future potential of this area of medical science. Our development pipeline also features potentially value-creating lifecycle projects that aim to expand and extend the reach of products in our existing portfolio."

... and how that contrasts with BYOT's vague seaweed project that, so far as I remember, wasn't developed with any disclosed commercial collaborators(- even though the patent seemed to suggest that the extraction method could result in a product that cures most illnesses:)).

The lack of BYOT's commercial ability and rigour has been evident for some years - also illustrated by the vagueness of the return or even calculated expectation on the licensing deals.

IMO new management is required whether or not it is delisted.

[loafofbread] 09/4/2024 06:56

Animalcare results out this morning. £27M in cash. MCap 2X turnover and 10X EBITDA.

Gives you an idea of what we should be valued at a few years out?

Inorganic growth
Pursuing external opportunities to drive sustainable growth is a strategic priority for the Group. This is reflected in the level of senior management focus dedicated to the identification and assessment of value-creating deals. Inorganic opportunities can manifest as M&A, in-licensing or partnering with the objective of expanding the make-up and reach of our existing portfolio or adding innovative new pharmaceutical products to the pipeline.

At all times Animalcare takes a disciplined approach to acquisitions and continues to see scope for further expansion with several prospects in development. We continue to identify plenty of opportunities giving us the confidence that we can execute attractive external deals aided by our strong financial platform.

Developing new products
Innovation is a key driver of growth in our industry. That's why we are increasing our R&D focus and capability on investigative drugs that we believe have the potential to change veterinary practice.

In 2022 we took a significant step to strengthen our novel pipeline in a pre-clinical collaboration and licensing deal with Orthros Medical, a Netherlands-based research company specialising in VHH antibody technology. Initially focused on treatment of osteoarthritic pain in dogs, we are now extending the investigative programme to horses. Overall, the project is progressing well and we are excited about the future potential of this area of medical science. Our development pipeline also features potentially value-creating lifecycle projects that aim to expand and extend the reach of products in our existing portfolio.

Strong foundations
Our future is being built on increasingly strong foundations. Financially, the reduction in our net debt from around £23.0m in 2019 to what was a net cash positive position of £1.7m at the 2023 year end, is a significant achievement and gives us more options as we continue to seek out value-creating opportunities.

Our balance sheet improved further in February 2024 with the disposal of UK-based Identicare Ltd. The sale of our majority stake in the non-core microchipping and pet owner-focused services company for £24.9m realised significant value for the Group and our shareholders. As a result, at the time of the announcement the Group's net cash position increased to around £27.0m.

[sikhthetech] 08/4/2024 20:18

bagsandbags

"Maybe. But it was also the last day of the tax year"

True, it was end of last tax year. The Newlands still have over 3% of TLY, they didn't sell out there, as no TR1 (so far!!!). In fact c40% of TLY is still held by Institutions. It'll be interesting if Newlands now end up increasing their holding in TLY...


Not long now to see if a white knight appears here before the vote. Otherwise I think it'll be delist or administration.

[mudbath] 08/4/2024 19:43

If our buyer wishes to continue adding then the Byotrol share price will need to rise again tomorrow in the cause of encouraging some selling, which today virtually dried up.
(Only 2million logged)

[kumbuka] 08/4/2024 18:14

Of course Mr and Mrs Newland will be unhappy with this worthless company but at least they have seen it and the sense to be voting with their feet.

Where stupid mudbath has spent the last few days stepping up the ramping of the company which he has done all the way from 9p DOWN

But oh no stupid mudbath is so arrogant on to admit he is wrong yet again.

Were you being paid to promote BYOT stupid mudbath ?

[mudbath] 08/4/2024 17:59

The Newlands must be unhappy investors being holders of STT's Totally in addition to their 99.9 % wipe at Byotrol.

[kumbuka] 08/4/2024 17:26

You should have thought about that before when you were ramping it doughy.

Mr and Mrs Newland can see that the company is worthless and have voted with their feet.

[kumbuka] 08/4/2024 15:55

Stupid mudbath you have been caught our RAMPING yet another company that has failed. I think it is a quite reasonable question to ask in the circumstances whether you were being paid by BYOT ?

As for the gang on mindless RAMPERS pigsbladder, 1gw and doughy they are now looking foolish and pigsbladder is hurting as he as lost thousands of pounds.

[kumbuka] 08/4/2024 15:48

Try all you will stupid mudbath but you just don't like being exposed.

[kumbuka] 08/4/2024 15:39

You are so angry with yourself pigsbladder for losing all your money. You deserve to lose after all your ramping.

Teach you to follow the stupid mudbath.

[kumbuka] 08/4/2024 15:33

It is you that is brainless pigsbladder. You have been ramping this POS non stop and now you lost your money.

A fool and his money is easily parted pigsbladder and you have been. I have no sympathy for you. You deserve it.

[kumbuka] 08/4/2024 15:24

How low will you stoop stupid mudbath. Your history of failed ramps goes before you.

What would be worse is if you are being paid ?

[kumbuka] 08/4/2024 15:17

Are you being paid by BYOT stupid mudbath ?

[kumbuka] 08/4/2024 15:16

Keep trying ramping crook.

[mudbath] 08/4/2024 15:10

0.1p on the bid coming soon to a broker near you !